Bulletin Kohl's results lag estimates as it slashes 2022 outlook »

Investor Alert

New York Markets Open in:

Gilead Sciences Inc.

NAS: GILD

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Gilead Sciences Inc.

Before the Bell

--Quotes are delayed by 20 min

May 19, 2022, 6:46 a.m.

GILD

/zigman2/quotes/210293917/composite

63.19

Change

-0.02 -0.05%

Volume

Volume 619

Quotes are delayed by 20 min

/zigman2/quotes/210293917/composite

Previous close

$ 63.22

Change

+0.04 +0.06%

Day low

Day high

$62.69

$63.93

52 week low

52 week high

$57.19

$74.12

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Gilead Sciences Inc.

View Ratios

Assets

Fiscal year is January-December. All values USD millions.	2017	2018	2019	2020	2021
Cash & Short Term Investments	26.15B	30.95B	24.67B	8.26B	7.41B
Cash Only	7.59B	17.94B	11.63B	6B	5.34B
Short-Term Investments	18.56B	13.01B	13.04B	2.26B	2.07B
Cash & Short Term Investments Growth	-	18.39%	-20.29%	-66.52%	-10.36%
Cash & ST Investments / Total Assets	37.20%	48.61%	40.03%	12.08%	10.90%
Total Accounts Receivable	3.85B	3.33B	3.58B	4.9B	4.49B
Accounts Receivables, Net	3.85B	3.33B	3.58B	4.89B	4.49B
Accounts Receivables, Gross	4.31B	3.91B	4.34B	4.94B	4.54B
Bad Debt/Doubtful Accounts	(455M)	(583M)	(758M)	(44M)	(47M)
Other Receivables	-	-	-	9M	-
Accounts Receivable Growth	-	-13.61%	7.66%	36.82%	-8.32%
Accounts Receivable Turnover	6.79	6.68	6.23	5.03	6.09
Inventories	801M	814M	922M	1.68B	1.62B
Finished Goods	-	-	-	-	-
Work in Progress	-	-	-	-	-
Raw Materials	-	-	-	-	-
Progress Payments & Other	-	-	-	-	-
Other Current Assets	1.03B	743M	1.12B	1.15B	1.26B
Miscellaneous Current Assets	1.03B	743M	1.12B	1.15B	1.26B
Total Current Assets	31.82B	35.84B	30.3B	16B	14.77B

	2017	2018	2019	2020	2021
Net Property, Plant & Equipment	3.3B	4.01B	5.17B	5.61B	5.66B
Property, Plant & Equipment - Gross	4.29B	5.2B	6.59B	7.28B	7.56B
Buildings	2.18B	2.34B	3.36B	3.68B	3.79B
Land & Improvements	396M	404M	404M	404M	404M
Computer Software and Equipment	-	-	-	-	-
Other Property, Plant & Equipment	494M	558M	634M	793M	807M
Accumulated Depreciation	994M	1.19B	1.42B	1.67B	1.89B
Total Investments and Advances	11.18B	1.57B	1.66B	2.26B	2.51B
Other Long-Term Investments	11.18B	1.57B	1.66B	2.26B	2.51B
Long-Term Note Receivable	-	-	-	-	-
Intangible Assets	21.26B	19.86B	17.9B	41.23B	41.79B
Net Goodwill	4.16B	4.12B	4.12B	8.11B	8.33B
Net Other Intangibles	17.1B	15.74B	13.79B	33.13B	-
Other Assets	2.7B	2.41B	6.6B	3.31B	3.22B
Tangible Other Assets	2.7B	2.41B	6.6B	3.31B	3.22B
Total Assets	70.28B	63.68B	61.63B	68.41B	67.95B
Assets - Total - Growth	-	-9.40%	-3.22%	11.00%	-0.67%

Liabilities & Shareholders' Equity

	2017	2018	2019	2020	2021
ST Debt & Current Portion LT Debt	2.75B	2.75B	2.6B	2.86B	1.62B
Short Term Debt	-	-	99M	107M	-
Current Portion of Long Term Debt	2.75B	2.75B	2.5B	2.76B	1.52B
Accounts Payable	814M	790M	713M	844M	705M
Accounts Payable Growth	-	-2.95%	-9.75%	18.37%	-16.47%
Income Tax Payable	713M	190M	287M	598M	539M
Other Current Liabilities	7.36B	6.88B	6.16B	7.09B	8.75B
Dividends Payable	-	-	-	-	-
Accrued Payroll	455M	555M	599M	864M	927M
Miscellaneous Current Liabilities	6.91B	6.32B	5.56B	6.23B	7.82B
Total Current Liabilities	11.64B	10.61B	9.76B	11.4B	11.61B
Long-Term Debt	30.8B	24.57B	22.72B	29.25B	25.67B
Long-Term Debt excl. Capitalized Leases	30.8B	24.57B	22.09B	28.65B	25.18B
Non-Convertible Debt	30.8B	24.57B	22.09B	28.65B	25.18B
Convertible Debt	-	-	-	-	-
Capitalized Lease Obligations	-	-	-	-	-
Provision for Risks & Charges	-	-	-	-	-
Deferred Taxes	(27M)	-	-	-	4.36B
Deferred Taxes - Credit	-	-	-	-	4.36B
Deferred Taxes - Debit	27M	-	-	-	-
Other Liabilities	7.35B	6.96B	6.5B	9.54B	5.25B
Other Liabilities (excl. Deferred Income)	7.35B	6.96B	6.5B	9.54B	5.25B
Deferred Income	-	-	-	-	-
Total Liabilities	49.78B	42.14B	38.98B	50.19B	46.89B
Non-Equity Reserves	-	-	-	-	-
Total Liabilities / Total Assets	70.83%	66.18%	63.25%	73.36%	69.00%
Preferred Stock (Carrying Value)	-	-	-	-	-
Redeemable Preferred Stock	-	-	-	-	-
Non-Redeemable Preferred Stock	-	-	-	-	-
Common Equity (Total)	20.44B	21.39B	22.53B	18.2B	21.07B
Common Stock Par/Carry Value	1M	1M	1M	1M	1M
Retained Earnings	19.01B	19.02B	19.39B	14.38B	16.32B
ESOP Debt Guarantee	-	-	-	-	-
Cumulative Translation Adjustment/Unrealized For. Exch. Gain	85M	47M	53M	51M	13M
Unrealized Gain/Loss Marketable Securities	194M	(52M)	1M	2M	(4M)
Revaluation Reserves	-	-	-	-	-
Treasury Stock	-	-	-	-	-
Common Equity / Total Assets	29.09%	33.59%	36.55%	26.61%	31.01%
Total Shareholders' Equity	20.44B	21.39B	22.53B	18.2B	21.07B
Total Shareholders' Equity / Total Assets	29.09%	33.59%	36.55%	26.61%	31.01%
Accumulated Minority Interest	59M	147M	125M	19M	(5M)
Total Equity	20.5B	21.53B	22.65B	18.22B	21.06B
Liabilities & Shareholders' Equity	70.28B	63.68B	61.63B	68.41B	67.95B

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Copyright © 2022 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and Cookie Notice ().
Do Not Sell My Personal Information

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Gilead Sciences Inc.

Annual Financials for Gilead Sciences Inc.

Assets

Liabilities & Shareholders' Equity

Latest News

dow

nasdaq

s&p 500

Kiosk